IbtiCare
Lausanne
About IbtiCare
IbtiCare has invented an innovative antibacterial technology based on Physical Vapor Deposition (PVD). This cutting edge technology can coat many surfaces with advanced nanoparticles and make them antibacterial against all types of dangerous bacteria that are resistant to any drugs. From many aspects, technology is superior compared to the current antibacterial methods. Their antibacterial technology has passed clinical trials and has been validated by operating leaders in healthcare.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $30.8K
- Last round: Grant (Jul 2017)
- Website: ibticare.ch
- Phone: +41 78 966 44 34
Industries & Categories
Health Care, Hospital, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/ibticare-2428563 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.